Could your gut protect you from toxic plastics?
Forever chemicals, also known as 'PFAS,' are long-lasting, synthetic chemicals that have been used in consumer products around the world since the 1950s. They're found in waterproof clothing, non-stick pans, plastic food packaging, and firefighting foams.
Exposure to the chemicals may be tied to negative health impacts, including fertility, developmental delays in children, a weakened immune system, increased cholesterol levels, and a heightened risk of some cancers. There are thousands of forever chemicals that have potentially varying effects and toxicity levels.
Now, scientists say they've discovered that some bacteria found in the human gut have the ability to absorb the chemicals — and potentially protect from associated health impacts.
'We found that certain species of human gut bacteria have a remarkably high capacity to soak up PFAS from their environment at a range of concentrations, and store these in clumps inside their cells,' Dr. Kiran Patil, a member of the British University of Cambridge's MRC Toxicology Unit, explained in a statement. 'Due to aggregation of PFAS in these clumps, the bacteria themselves seem protected from the toxic effects.'
Patil was the senior author of the research, which was published in the journal Nature Microbiology.
To reach these conclusions, the researchers inserted several species of bacteria from the human gut into mice. The study found that nine species of the bacteria gathered the forever chemicals the rodents ate and then pooped out.
When exposed to increasing levels of the chemicals, the bacteria worked even harder, consistently removing the same percentage of the toxic chemicals. Within just minutes of exposure, the bacterial species soaked up between a quarter and nearly two-thirds of the forever chemicals.
The same effect has not yet been tested in humans, but the researchers said they plan to use their findings to create probiotic dietary supplements that boost the levels of these species in the gut to shield against any PFAS-related health harms. They are also looking at how they could turbo-charge the species' performance.
'The reality is that PFAS are already in the environment and in our bodies, and we need to try and mitigate their impact on our health now,' Dr. Indra Roux, a researcher at the University of Cambridge's MRC Toxicology Unit and a co-author of the study, said.
Until then, the researchers say the best thing people can do to protect themselves is to avoid known risks for exposure. Although, even tap water has been contaminated: nearly half of all tap water in America.
Under the Trump administration, the Environmental Protection Agency moved to weaken Biden-era standards limiting the pollution of potentially-toxic 'forever chemicals' in U.S. drinking water sources earlier this year.
'PFAS were once considered safe, but it's now clear that they're not,' added fellow researcher Dr. Anna Lindell. 'It's taken a long time for PFAS to become noticed because at low levels they're not acutely toxic. But they're like a slow poison.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Ozempic Alternative Ditches The Needle And One Major Side Effect
A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to a new study. Although its efficacy hasn't yet been tested in humans, the compound could bypass some of the harmful side-effects associated with similar drugs. Unlike the famous family of GLP-1 receptor agonist drugs, this new candidate targets the β2-adrenergic receptor (β2AR). Drugs that do this aren't new: salbutamol (sold as Ventolin among other brand names) is widely prescribed for use in short stints to treat asthma and chronic obstructive pulmonary disease. Clenbuterol is also prescribed for asthma in some countries, though it's better known as a performance-enhancing drug, banned by the World Anti-Doping Agency for its anabolic effects. For more than a decade, scientists have been trying to find a way to harness the benefits of β2AR agonists, without setting off their harmful effects. They can stimulate skeletal muscle glucose uptake and burn fat, mimicking the effects of exercise – but they have been considered too risky for treating diabetes or obesity, because of their tendency to wreak havoc on the heart. Related: The body's β2-adrenergic receptors are coupled with G proteins, and when activated for long periods (by β2AR drugs, for instance), the G proteins set off a chain reaction which leads to cardiovascular problems. "That would lead to heart rate increases, systolic blood pressure increases, and, eventually, that over-sustained exposure would lead to increases in heart weight and cardiac hypertrophy," molecular biologist Shane Wright, from Karolinska Institute in Sweden, told Mar de Miguel of Bioworld. But a campaign led by scientists from the Karolinska Institute, Stockholm University, and the biotech company Atrogi AB has revealed a series of β2AR agonist molecules that can side-step the slippery slope triggered by the G proteins. By activating only specific pathways, one of these – dubbed 'compound 15' – seems less likely to cause those concerning side effects, though we won't know for sure until further clinical trials are carried out. Unlike GLP-1 receptor agonists like Ozempic, compound 15 doesn't suppress appetite or lead to muscle loss, which means it may be safer in that regard too. It's also much more user-friendly, as a drug that can be swallowed rather than injected. "The goal was to try to target this other action that this receptor has expressed in the skeletal muscle, not in the heart, where it is mediating glucose uptake as a very beneficial outlet for lowering blood glucose levels," Wright said. So far, the newly-designed drug has been tested in lab-grown cells, male mice, rats, beagles, and phase 1 clinical trials (which only test for safety, not efficacy) in healthy and type 2 diabetic men. "Lead candidates of the chemical series increased glucose tolerance in preclinical models of diabetes and obesity with little or no increase in contractile force, cardiac lesions, and cardiac hypertrophy," the authors report. They also reversed muscle atrophy induced by GLP-1 drugs. "Clinical evaluation demonstrated that our lead candidate was orally bioavailable and safe in both healthy volunteers and type 2 diabetics, underlining its therapeutic potential." Many more tests – and a catchier name – will be needed before compound 15 or its relatives are made available as an alternative to GLP-1 drugs. Phase 2 clinical trials are underway to see if the enhanced muscle growth, balanced glucose levels, and insulin sensitivity seen in animal tests hold up in human bodies. "A well-tolerated GRK2-biased agonist offers significant therapeutic potential beyond type 2 diabetes and obesity… like muscular dystrophy and sarcopenia," the authors add. The research was published in Cell. A Simple Change To Your Evening Routine Could Help You Exercise More 'Sky-High' Levels of Alzheimer's Protein Found in Newborns Alzheimer's Might Not Actually Be a Brain Disease, Says Expert
Yahoo
an hour ago
- Yahoo
First Step Towards an Artificial Human Genome Now Underway
As if sequencing a full human genome wasn't tricky enough, scientists are now attempting to reconstruct our species' genetic material from the ground up. It's an ambitious and controversial project called the Synthetic Human Genome (SynHG) project, and work has already begun on a proof-of-concept. The goal of this crucial first step is to use the human genome blueprint to write the genetic code for a single, enormously long strand of DNA in just one of our chromosomes – making up approximately 2 percent of our total genome. The entire DNA content will be digitally designed before it is then built in the lab. According to proponents, this project could kickstart a genetic revolution, profoundly changing our understanding of human DNA and possibly enabling designer cell-based therapies and virus-resistant tissue transplantation. Related: Emboldened by these futuristic possibilities, the Wellcome Trust – one of the world's largest scientific research charities – announced this week that it was funding the SynHG initiative with £10 million (approximately US$13.7 million). Researchers behind the project, who hail from the Universities of Oxford, Kent, Manchester, Cambridge, and Imperial College London, told the BBC that "the sky is the limit". They aim to build a fully synthetic human chromosome in the next five to 10 years. "The ability to synthesize large genomes, including genomes for human cells, may transform our understanding of genome biology and profoundly alter the horizons of biotechnology and medicine," says project leader and molecular biologist Jason Chin from the Ellison Institute of Technology and Oxford. "With SynHG we are building the tools to make large genome synthesis a reality." Some independent scientists, however, are dubious that the SynHG project can get that far, even with cutting-edge generative AI and advanced robotic assembly technologies. Award-winning geneticist Robin Lovell-Badge from the Francis Crick Institute, who is not involved in the SynHG project, says that he is "very enthusiastic" about the initiative, as "you can only truly understand something if you can build it from scratch." But despite all the knowledge we have gained since fully sequencing and reading the human genome in 2003, he says there is still a lot of work to be done before we can actually build a complete one. Today, the only human-made genomes fully written from scratch are for single-celled organisms that have, at most, 16 chromosomes made from roughly 12 million base pairs. That accomplishment took roughly a decade of hard work. Humans, by comparison, typically possess more than 30 trillion cells with 46 chromosomes and 3 billion base pairs. Who knows how long it will take scientists to untangle that level of complexity? "As for synthetic human chromosomes, although the current project is very unlikely to get that far, it may eventually be possible to make synthetic cells that can be grown in the lab with high efficiency," says Lovell-Badge. "However, there is no suggestion to make synthetic humans. We have no idea how to do this, and it is likely to be very unsafe." While the details are hazy, the SynHG team claims to be working with academic, civil society, industry, and policy experts to examine the ethical, legal, and social implications of their research. Projects like these are bound to inspire social and ethical debates on the possibilities and consequences of complex health and reproductive issues, from the right to make 'designer' babies to the definition of eugenics. "We must recognize that this sort of work is not without controversy, and that is vital for researchers and the public to be in communication with one another," says Sarah Norcross, director of the Progress Educational Trust (PET), which is a charity for people affected by genetic conditions. "The public must have a clear understanding of what this research entails, while researchers and funders must have a thoroughgoing understanding of where the public wants to go with this science." Nightmares Could Make You 3 Times More Likely Die Before 75 The Secret to Better Sleep Could Be As Simple As Eating More Fruit And Veggies BMI Is an Awful Predictor of Early Death. We've Had a Better Option For Decades.
Yahoo
an hour ago
- Yahoo
Pupils give up smartphones in behaviour experiment
Pupils at a school in Kent have given up their smartphones as part of an experiment to monitor their behaviour. Year 10 students at The Canterbury Academy Trust who handed in their phones said it was a "scary" prospect, but also "a relief". As part of a research project by the University of Kent, the pupils will not have access to their smartphones for one week. Experts said they wanted to track the change in the behaviour of students and the impact it has on them. Emilia and Molly handed in their smartphones on Monday morning. Molly said: "It's a nice bit of freedom because you don't have to constantly be checking your messages and see you're missing out on things." Meanwhile, Emilia added: "I think it's going to improve our mental health and mental wellbeing because you're not constantly looking at your phone, you can actually get on with things that you're meant to." The pupils have been given a basic Nokia phone for the week, with no access to social media. Jon Watson, chief executive officer of The Canterbury Academy Trust, is also taking part in the trial, which has previously been carried out at two Kent schools. He said phone use was already restricted during the school day, but the experiment included when staff and pupils returned home. "I thought it was important that I set that example, so that I can be present and in the moment," he said. "It's about helping young people understand the power and responsibility they have when they are in possession of a smartphone, how positive they can be in terms of what they can do, but also some of the negatives and some of the challenges they'll face while they have that mobile phone as well." Participants are to be interviewed at the start and at the end of the week by Dr Lindsey Cameron, a psychology lecturer at the University of Kent. "We know there's a link between smartphone use and mental health, problems with sleep, comparing yourselves to others - and phones are really addictive. "We really have to understand what effect this is having on young people." This week, six primary schools and more than 5,000 parents and caregivers in Kent signed up to a pact that promised to delay smartphone use in teenagers until Year 9 and access to social media until two years later. More schools are due to take part in the experiment in the coming months and a summit involving teachers from schools across Kent is to be held in September to discuss a cross-county approach to smartphones. Follow BBC Kent on Facebook, on X, and on Instagram. Send your story ideas to southeasttoday@ or WhatsApp us on 08081 002250. University of Kent The Canterbury Academy Trust Thousands of parents support under-14 phone ban Parents get forum to air smartphone access concerns
